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Part A - Study protocol 
Study title: Predictive model correlating pre-operative findings with intra-operative 
cholangiogram results 
Principle Investigators: Dr JC Kloppers, Dr JH Klopper 
Co-investigator: Dr Mohamed Ali M Elmusbahi 
 
Introduction and background: The first intra-operative cholangiogram series was published 
in 1931 by Mirizzi during the exploration of the common bile duct (CBD) for stones. This 
development came at a critical period when complications following biliary surgery were both 
common and serious1. 
 
An intraoperative cholangiogram (IOC) is the fluoroscopy image of the biliary tree during 
laparoscopic cholecystectomy, which can be done routinely or selectively2.  
 
There is no convincing data to suggest that routinely performed IOC reduces the incidence of 
retained CBD stones after laparoscopic cholecystectomy. It, however, increases cost and 
prolongs operative time3. Furthermore, imaging misinterpretation can lead to false-positive 
studies and unnecessary post-operative invasive procedures. 
 
The indication for selective IOC would be abnormal liver enzymes and/or dilated biliary tree 
on pre-operative ultrasound4. This group of patients would be categorised as intermediate 
risk for CBD stones. Patients with mild acute biliary pancreatitis would also fall into this group. 
Jaundice patients would be high risk and thus justify pre-operative endoscopic retrograde 
cholangiopancreaticogram (ERCP)5. This reflects our current practice6. 
 
A filling defect on IOC can lead to operative CBD exploration, post-operative ERCP or 
observation with clinical and imaging follow up7,8. 
 
As seen in the literature, there are no universal guidelines for the use of IOC. There are two 
other role-players in MRCP and endoscopic ultrasound for the pre-operative imaging of the 
bile duct9, but in a resource scares environment, this cannot be accessed routinely. Our study 
will investigate if the patients currently selected for IOC (deranged liver enzymes, dilated 
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biliary tree & mild acute pancreatitis) have their management changed by this procedure. 
Primary endpoint being further positive intervention done in the case of a positive finding on 
IOC (filling defect or contrast not draining). 
 




Primary Objective: Which pre-operative finding correlates with a positive IOC leading to 
further interventions? 
Secondary objectives: Follow up negative IOC’s for any adverse outcomes. 
 
Materials and methods 
Study design: A retrospective cohort analysis of a prospectively maintained database.  
 
Study settings: Operative databases of both the Acute Care Surgery Unit and Hepatobiliary 
Surgery Unit will be used to identify all patients who underwent IOC during laparoscopic 
cholecystectomy (lap chole). Data on patients’ demographic characteristics, indication for lap 
chole, history of pancreatitis, history of jaundice with pre-operative findings of LFT’s and 
ultrasound will be collected. IOC findings will be documented and postoperative course of 
these patients. The information on the database will be exported into an Excel spreadsheet 
for analysis.  
 
Time Period: From 1st January 2015 to 31st December 2016 
 
Data Analysis: Data will be described in means and standard deviations for normally 
distributed data and medians and confidence intervals for non-parametric data. 
 
Justification for the chosen timeline: Two-year period where electronic patient records are 
available. The start date was when the database was implemented, numbers needed to fulfil 
sample size calculations, or previously reported studies had used this timeframe. 
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Inclusion Criteria: All patients who were investigated with an IOC during laparoscopic or open 
cholecystectomy. 
 
Exclusion Criteria: Incomplete reporting of IOC or bile duct injuries.  
 
Ethics approval: Approval will be obtained from the UCT Human Research Ethics Committee 
and the Departmental Regulatory Board (DRB). Data and all appropriate documentation will 
be stored for a minimum of five years after the completion of the study, including the follow-
up period.  
 
Consent: No consent is required since this a retrospective analysis of patient records 
Confidentiality: The Principal Investigator will preserve the confidentiality of participants 
taking part in the study in compliance with data protection legislation. 
Anonymity will be ensured with the use of a master code, which will be kept in a separate 
secure filing cabinet. All computers will be password protected. 
 
Indemnity: UCT holds a non-negligent harm insurance policy that applies to this study. 
 
Sponsor: UCT will act as the main Sponsor for this study. Delegated responsibilities assigned 




Audits: The study may be subject to inspection and review by UCT CRC under their remit as 
Sponsor and other regulatory bodies to ensure adherence to South African Good Clinical 
Practice if required. 
 
Publication Policy: Authorship will be based on substantial contribution to the conception, 
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Part B - Literature review 
Choledocholithiasis 
 
Literature search strategy 
A structured literature review was completed searching the electronic databases of PubMed, 
Google Scholar, and UpToDate using the search thread (cholelithiasis) or (choledocholithiasis) 
or (intraoperative cholangiogram). Additional manual searches of the Cochrane Library were 
performed. References were crossed checked. Only human studies in English were included. 
 
Incidence and clinical manifestations  
The first laparoscopic cholecystectomy was performed in 1990. Since then laparoscopic 
cholecystectomy has become one of the most common surgical operations worldwide1. 
Cholelithiasis affects up to 21% of the general population and more than 75% are females2. 
Choledocholithiasis is found in 11 to 20% of patients with cholelithiasis, a significant 
proportion may be asymtomatic3. The majority of cases of choledocholithiasis result from the 
migration of gallbladder stones (secondary choledocholithiasis) to the common bile duct and 
less commonly from stone that forms in the bile duct (primary choledocholithiasis). 
 
Pain and obstructive jaundice are the most common features. The pain differs from biliary 
colic in that it lasts longer with sudden relief when the common bile duct (CBD) stone pass or 
being removed. Obstructive jaundice associated with or without pain is also a common 
presentation. Asymptomatic stones are not an uncommon presentation which can be 
detected with ultrasound (U/S) or abnormal liver function test (LFT)4. According to the 
presenting symptoms, it is classified as an uncomplicated - or complicated presentation. Some 
patients have a phenomenon called the “ball-valve” effect; it is an intermittent pain as a result 
of a small stone which causes a transient blockage or floating in CBD5. 
 
The most serious complications are the result of bile flow obstruction which lead to infection 
of bile causing ascending cholangitis. Gallstone pancreatitis is a result of pancreatic duct 






In spite of a wide variety of examinations and investigations there are two necessary 
questions in the intermediate group to consider: 
1) How to cost-effectively diagnose a CBD stone 
2) The best strategy for dealing with a CBD stone once it is detected 
The diagnosis of CBD stones are made by history, clinical examination, laboratory tests (LFT, 
and serum lipase) and imaging (transabdominal U/S, MRCP, ERCP, EUS, and IOC)7. 
 
Liver enzymes ALT and AST might be raised early in the passage of CBD stones. Progressively, 
liver function tests are typically elevated in a cholestatic picture, with increases in bilirubin 
and ductal enzymes ALP and GGT more prominent than elevation in serum ALT and AST. 
Numerous authors have tried to evaluate the predictive value of liver function tests for 
choledocholithiasis8–10. A meta-analysis of 22 studies estimated the predictive role of multiple 
examination findings and criteria used in the identifications of choledocholithiasis, including 
bilirubin and ALP12. An increase in bilirubin level had a sensitivity of 69% and a specificity of 
88% for diagnosing CBD stones. For elevations in serum ALP, the values were 57% and 86%, 
respectively. 
 
A study of 1002 patients, who underwent laparoscopic cholecystectomy for cholelithiasis, 
evaluated five liver function tests for predicting choledocholithiasis: GGT, ALP, total bilirubin, 
ALT, and AST10. The sensitivities ranged from 64% for AST to 84% for GGT, and the specificities 
ranged from 68% for ALT to 88% for bilirubin. Raised GGT, ALP, and bilirubin levels were 
independent predictors of a CBD stone on multivariable analysis. 
Since liver function tests may be elevated due to a wide variety of causes, the positive 
predictive value of raised liver function tests is inadequate. Oppositely, the negative 
predictive value of normal liver function tests is high. Accordingly, normal liver function tests 
play a more significant role in excluding choledocholithiasis than elevated liver tests play in 






Several imaging modalities can confirm the presence of CBD stones 





Transabdominal U/S is the initial imaging test of choice for upper quadrant pain, which can 
evaluate cholelithiasis or choledocholithiasis and dilatation of the CBD. It is cheap, non-
invasive and can be performed by the bedside11. The sensitivity ranges from 20% to 90% for 
detecting choledocholithiasis as it is operator depended with a specificity of 91%12. 
Ultrasound has a very low sensitivity for distal CBD stones which usually are obscured by 
bowel gas in the image field13. A dilated CBD is suspicious for a distal CBD stone, but it is not 
specific for choledocholithiasis14. A normal CBD on U/S is about 6 mm15,16, the probability of 
CBD stones increased with an increase of CBD dilatation:  
0 to 4 mm: 3.9% 
4 to 6 mm: 9.4% 
6 to 8 mm: 28% 
8 to 10 mm: 32% 
>10 mm: 50% 
CBD diameter increases with age, so a patient above 60 years could have a normal CBD above 
6 mm17–19. 
 





Figure 2 Stone (arrow) and dilated CBD21. 
Endoscopic retrograde cholangiogram (ERCP) is an invasive test which carries complications 
such as bleeding, perforation and acute pancreatitis. Therefore, expertise is required to 
perform the procedure. Previously it was used for diagnosis and therapy for CBD stones, but 
now it is reserved for the high-risk group. ERCP has a sensitivity for CBD stones of 80–93% and 
specificity of 99–100%22,23. 
 
 
Figure 3 ERCP demonstrate a stone (arrow) within CBD24. 
Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive modality and does 
not require an injection of a contrast medium into the biliary system which makes it very safe. 
The disadvantage of MRCP is its diagnostic nature and it does not permit interventions like 
stone extraction. It also has a lower resolution than ERCP and therefore small stone (<4 mm) 




Figure 4 MRCP shows a stone within the distal CBD (arrow)27. 
Endoscopic ultrasound (EUS) is less invasive than ERCP and has a sensitivity of 94% and 
specificity of 95% in a validated user28. Due to its unavailability, it is hardly ever used in the 
diagnostic workup for CBD stones.  
 
 
Figure 5 EUS is demonstrating stone (arrow) within CBD29. 
 
Figure 6 EUS shows microlithiasis (arrow) within GB29. 
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Intra-operative ultrasound (IOU) is another approach for detecting CBD stones with a 
sensitivity of 90% with the advantage of no CBD entry. It implies less bile duct injuries 
compared to IOC but requires surgeon's expertise and comfort with the techniques30,31. 
 
Figure 7 IOU of hepatoduodenal ligament reveal Micky mouse appearance32. 
Intra-operative cholangiograms (IOC) accurately detect CBD stones with a sensitivity of 59% 
to 100% and specificity of 93% to 100%. It might also reduce or at least assist with early 
diagnosis of CBD injuries during cholecystectomy. IOC can be performed during open or 
laparoscopic cholecystectomy. The advantage of IOC is that the surgeon can deal with findings 
intra-operatively by flushing the duct, extract stones with a Fogarty's catheter, perform a CBD 
exploration, or ERCP post-operatively. IOC both maximise and minimise the use of ERCP33–35. 
 
The ongoing debate is if IOC should be performed routinely or selectively, with no clear 
consensus which is superior. Most surgeons perform IOC selectively as it is time-consuming 
and false-positive results can lead to unnecessary CBD exploration36. Selective IOC is 
performed in the intermediate group as described earlier. 
 
The routine IOC is performed in every case of laparoscopic cholecystectomy regardless of the 
pre-operative LFTs or U/S. In the past IOC was used in open cholecystectomy as described by 
Mirizzi37. Routine IOC aims to reduce a bile duct injury by demonstrating the bile duct 
anatomy and reduce retained CBD stones. Some reports find the incidence of CBD injury to 
be 0.1-0.3%38 but others report much higher up to 1.4%39. The other advantage of a routine 
IOC is to keep surgeons exposed to the procedure. In addition, the use of a routine IOC can 
detect a CBD injury, but not reduce the risk40. Although, some studies find that it can reduce 
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the CBD injury in up to 70%39. The additional time consumed by an IOC (16 minuntes) and the 
false-positive result of CBD stones made the routine use of IOC a debatable subject41. 
Additionally, in eight randomized trials no one demonstrated a clear benefit of routine IOC to 
reduce retained stones42. 
 
Surgeons tend to move towards a selective use of IOC depending on the risk factors as 
described in table 1. Hereby aiming to reduce the time of the operations, decrease false-
positive results and to minimize the handling of the biliary system. The selection of the 
patients depends on the ASGE guideline 201943. A history of jaundice, raised liver enzymes 
and U/S abnormality select patients to the intermediate-risk group for which selective use of 
the IOC is recommended44. 
 
 
Figure 8 IOC demonstrating a 10-mm CBD stone (arrow)45. 
 
Risk assessment 
The assessment for CBD stones must use the least invasive and cost-effective investigation to 
confirm or exclude CBD stones. The guidelines propose dividing patients into three groups 
according to the risk of choledocholithiasis (2019 guidelines)43. In other words, risk 




























Very strong predictors 
 
The presence of a common bile duct stone on 
transabdominal ultrasound 
Clinical acute cholangitis, A serum bilirubin greater 




A dilated common bile duct on ultrasound (more than 
6 mm in a patient with gallbladder in situ) 
A serum bilirubin of 1.8 to 4 mg/DL                                




Abnormal liver biochemical test other than bilirubin 
Age older than 55 years 
Clinical gallstone pancreatitis 
High-risk groups 
 
At least one very strong predictor and/or 
both strong predictors 
Intermediate-risk groups 
 
One strong predictor and/or 






Using the above predictors, patients are stratified in a high-risk, intermediate-risk and low-
risk group. 
 
Those who are categorised into the high-risk groups are estimated to have more than 50% 
likelihood of choledocholithiasis43. For these patients, the initial management is ERCP to treat 
any CBD stones before cholecystectomy46. 
 
The intermediate-risk group is estimated to have CBD stones between 10-50% of the cases47. 
This group need further evaluation for CBD stones. The incidence does not warrant the risk-
benefit of doing a pre-operative ERCP. The biliary tree can be imaged with an MRCP, IOC or 
EUS. The decision depends on multiple factors such as cost, patient factors, availability of 
MRI/EUS and suspicion for small stones. MRCP is one option in the intermediate-risk group 
and if it is positive, proceed with an ERCP before cholecystectomy. EUS is further option, but 
equipment and skills are less available. It is also procedural with the associated risk although 
less than ERCP. There is no difference between IOC and EUS regarding complications, 
conversion to open or mortality. The only difference is hospital stay with the EUS group 
slightly longer than for the IOC group48. 
 
Low-risk patients are estimated to have CBD stones in less than 10% and for this group 




It is generally accepted that patients with choledocholithiasis should have the biliary system 
cleared of stones. This can be achieved via surgery (open or laparoscopy) or 
endoscopically49,50. As the majority of choledocholithiasis is the result of the migration of 
cholelithiasis to the common bile duct, part of the management is a cholecystectomy as a 
one-step or two steps procedure43. A meta-analysis of 16 published randomised trials 
evaluated which strategy is superior and did not show any significant differences in morbidity 
or mortality51. The incidence of a retained CBD stone was significantly less in open CBD 
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exploration compare to the two-step procedure. Management by laparoscopic CBD 
exploration is associated with a shorter hospital stay52,53. 
A one-stage procedure is to perform an ERCP intraoperatively with a laparoscopic 
cholecystectomy. As seen in the literature it needs two teams to perform the procedure. Also, 
it requires a well-equipped theatre. A one stage procedure is associated with less pancreatitis: 
0.6% comparing to 4.4% to the two-stage procedure. Also, the overall morbidity is higher in 
two-stage procedure 11% comparing to one stage procedure 6%. The one-stage procedure 
has a shorter hospital stay where the two-stage procedure needs two admissions and 
anaesthetics. The trails concluded that the one-stage procedure is better financial value than 
the two-stage procedure54 
Endoscopic management 
ERCP was first performed in 197455 and since then it has become the most broadly practised 
technique for diagnosing and management of choledocholithiasis56. 
The procedure involves the identification of the papilla of Vater, then cannulation of the duct 
to perform a biliary sphincterotomy followed by extraction of the CBD stones by balloon or 
basket. The complications can vary widely according to the indication rather than the age or 
comorbidity. The morbidity is 5% to 9.8%, and the mortality of 0.3 to 2.3%46. The 
complications include bleeding, perforation and acute pancreatitis57,58. The timing of the 
procedure can be before surgery, during (rendezvous technique) or after the 
cholecystectomy. 
 
Pre-operative endoscopic management is indicated in the high-risk group (Table 2), followed 
by cholecystectomy after clearing the common bile duct. Intra-operative endoscopic 
management (rendezvous technique) or one-step procedure could be a very eloquent 
solution. However, it is rarely performed in developing countries where it needs another team 
with ERCP hardware and disposables in the operating room when it is indicated if the IOC 
demonstrates CBD stones59. Post-operative endoscopic management or a two-step 
procedure is indicated when a positive IOC needs an ERCP to clear the CBD, which is 
commonly performed in our setting. Failure to achieve post-operative endoscopic clearance 
of the duct can necessitate a second operation60,61. This strategy should not be followed if the 
stones are clearly not amenable to endoscopic treatment as judged on the IOC. Large stones 
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or a big stone burden should be considered for immediate CBD exploration, although they are 
likely to have been diagnosed pre-operative. 
 
Endoscopic papillary balloon dilatation (EPBD) was introduced to minimise the sphincter 
damage and assist in the delivery of large stones. It is performed with a minimal 
sphincterotomy and has been used for high bleeding risk patients or those who have difficult 
anatomy to perform a full sphincterotomy e.g. periampullary diverticulum. After biliary 
cannulation and limited sphincterotomy, a dilatation balloon is advanced over the guidewire 
and inflated. The balloon sizes vary from 8-20 mm and the size of the duct on initial 
cholangiogram should be used as a guide in order not to rupture the duct. The advantage of 
minimal sphincterotomy and balloon dilatation has decreased the risk of bleeding and lower 
infection rate, but the disadvantage is a higher recurrence rate62–64. 
 
Endoscopic mechanical lithotripsy (EML) is a strategy for difficult common bile duct stones 
that cannot be extracted by Dormia basket or balloon catheter. The lithotripsor consists of a 
hardwire basket with a metal spiral sheet. When the stone is captured in the basket and pulled 
back to the rigid sheath, the stone can be crushed by an out of scope lithotripsor65. This 
technique has been updated by a through the scope lithotriptor, which could reach 80% to 
90% clearance of the common bile duct66. Failure of mechanical lithotripsy could be when the 
common bile duct stone is too big to be captured by the basket or when the stone is impacted 
in the distal common bile duct49. A complication can occur when it is not possible to crush a 
captured stone with the device stuck in the duct which will dictate surgical removal. 
 
Endoscopic electrohydraulic lithotripsy (EEL) was first used in 1975 through a T-tube tract 
under fluoroscopy guidance67. Modern-day use would be with a through the scope 
cholangioscope (SPYGLASS system) where the duodenoscope and cholangioscope (spyscope) 
are controlled by the same endoscopist. By performing electrohydraulic lithotripsy using a 3-





Endoscopic laser lithotripsy (ELL) is used under direct vision through a cholangioscope 
(SPYGLASS) to avoid heat-induced injury to the biliary system. Clearance of the common bile 
duct can be achieved through this technique between 93% to 97% of the times69.  
 
SURGICAL MANAGEMENT 
Open procedures were the standard of care for clearing of CBD stones in the 1980s. It is 
performed through an open CBD exploration or rarely duodenotomy plus sphincterotomy. 
Nowadays, it considered the last resort in difficult CBD stones. Still, a recent study showed it 
is superior to ERCP for clearing CBD stones in 96% to 98% of cases with no significant 
differences in morbidity (20% vs 19%) and mortality (1% vs 3%)51.  
 
Since the laparoscopic era, CBD exploration can be performed this way. In expert hands, it is 
as useful as ERCP for clearing the common bile duct. However, it takes longer (300-358min)70 
than for a simple cholecystectomy. When one reaches a critical view of safety and a CBD stone 
is identified by IOC or intra-operative U/S, the first attempt could be to irrigate the CBD 
through the cystic duct aiming to clear the CBD. If it fails a choledochotomy performed along 
the CBD to allow introducing a choledochoscope to extract the stones by Dormia basket or 
balloon extraction5,61.  
 
Intra-operative cholangiogram procedure 
The most common indication for IOC is for the diagnosis of CBD stones. Other indications such 
as clarification of biliary anatomy to facilitate the dissection or to prevent biliary injuries might 
be used. Moreover, it can identify other abnormalities like biliary leaks or strictures. There 
are several techniques described to perform IOC. The most common are Kumar (through the 
gallbladder) and Olsen (through the cystic duct) cannulation techniques. There is no one 
proven to be superior to another, so surgeons can use either of them depends on which is 
preferred71.  
 
The additional equipment needed to perform an IOC includes: on table fluoroscopy, 
commercial pre-packed cholangiogram kit which consists of a catheter or a cannula, a syringe, 
introducer needle/sheath, a 3-way stopcock (figure 11), and contrast medium. In limited 
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resources institutions, the cholangiogram can be done by a urethral catheter (size: 3 Fr) and 
reusable cholangiogram clamp instrument (Olsen’s forceps)72. 
 
During laparoscopic cholecystectomy, after achieving the critical view of safety, a clip is 
applied to the proximal cystic duct to avoid spillage of bile and stones from the gallbladder. A 
small cystic ductotomy can be made (the Olsen method) to facilitate the catheter to advance 
into the biliary tree by using an Olsen clamp (figure 10). If a commercial set is used, a small 
stab incision in the upper right quadrant in a place of convenience can be made to pass the 
cholangiogram catheter percutaneously into the cystic ductotomy. The catheter should be 
temporarily fixed by inflating the balloon, cystic duct holding device or umbrella mechanism. 
If the critical view of safety cannot be achieved, a cholangiogram needle is inserted into 
Hartmann’s pouch of the gallbladder using a Kumar clamp to secure the needle (The Kumar 
method as in figure 9). 
 
After succeeding with access to the biliary tree, good flow can be confirmed by flushing with 
saline and this also avoids contrast spillage, which could obscure the fluoroscopy image. If the 
biliary tree is dilated one could dilute the contrast 50/50 with saline to not miss small filling 
defects in dense contrast. Great care should be given to avoid injection of air bubbles which 
could lead to a false positive study. When screening, request apnoea form the anaesthetist 
and place the patient in right tilt Trendelenburg position to obtain the best quality image of 
the hepatic biliary system. Care should be taken to identify any anatomical variation. Change 
patient position to anti-Trendelenburg to visualize and dynamic timing of the contrast going 
into the duodenum. 
Additionally, this manoeuvre facilitates the air bubbles to move superiorly. Air bubbles can 
also be recognised from actual filling defect by them joining each other. If there is a delay in 
emptying, glucagon 1-2 mg intravenous can be administered to relax the sphincter of Oddi. If 
a delay persists in emptying of the biliary system into the duodenum, it could be a distal 
obstructed stone and one should be vigilant to look for a cresent64. In theory, a complete cut 
off should raise the suspicion of a CBD injury. 
 
If there is difficulty to insert a cholangiogram catheter caused by a stone in the cystic duct, 
the surgeon can perform a milking manoeuvre to remove it through cystic duct incision. If 
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milking the stone out is unsuccessful or the cystic duct has a sharp angle, a guidewire can be 
inserted following with catheter sheet over it. Avoid overfilling of the biliary tree with contrast 
solution as a small stone can be missed. A filling defect can represent an intraluminal tumour, 
air bubbles or most likely stones. As mentioned before, care should be taken by flushing with 
saline before and after the injection of the contrast and screening from deferent angles while 
moving the patient can help to differentiate between the filling defects71–73.  
 
A positive IOC is depended on biliary dilatation with a filling defect. Failure of passage of the 
dye with other signs also should be noticed like a stricture or a leak but it does not reflect a 
positive IOC. The interpretation is different from surgeon to another or from surgeon to 
radiologists so that makes the false-negative of 1.5% and false-positive IOC of 2.0%. There is 
a report comparing surgeon versus radiological interpretation of a IOC which demonstrates a 
substantial difference between both teams with poor interpretation by surgeons. However, 









Figure 11 commercial cholangiogram kit. 
 
Conclusion 
Figure 12 summarizes a diagnostic and treatment algorithm for suspected CBD stones. 
These modalities are not always readily available and practical in the South African health 
care setting. There is a paucity of data on the local disease profile and treatment. However, 
despite deficit studies on internal management of choledocholithiasis, it should be noted 
that a retained CBD stone post laparoscopic cholecystectomy may lead to serious 
complications. Therefore, patients should be categorised according to the prediction of 
having a CBD stone to minimise the sequences of a missed  CBD stone. In our setting a IOC is 
a suitable choice for diagnosing and further treating of the intermediate-risk group of CBD 





























Symptomatic patients with 
cholelithiasis 
Likelihood of choledocholithiasis on 
clinical predictors (Table 2) 
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*depend on costs and local expertise  







Figure 12 The American Society for Gastroenterology Endoscopy algorithm for the management of patients with symptomatic 
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Background: The most common investigations used in the pre-operative diagnosis of 
choledocholithiasis are ultrasound and liver function tests (LFTs). These modalities have a low 
sensitivity for detecting common bile duct stones amongst the intermediate-risk groups. 
 
Aim: Identify pre-operative findings which predict choledocholithiasis in intermediate-risk 
groups. Describe the implications of a positive intra-operative cholangiogram (IOC). 
 
Method: A retrospective study of all consecutive laparoscopic cholecystectomies with IOC 
performed. Data were collected over two years between 1st January 2015 and 31st December 
2016. Standard demographic variables, preoperative symptoms, LFTs, IOC findings, abdomen 
ultrasound, and postoperative symptoms were included. 
 
Results: 23 cases were planned for IOC. The median age was 41 years. Seventeen cases were 
females. Indications were 12 biliary colic, eight gallstone pancreatitis, two cases of acute 
cholecystitis, and one case was for ascending cholangitis. Four cases had a positive IOC, and 
in this group, the median age was 44.5 years with one male. The mean common bile duct 
diameter was 6.5 mm. Two patients had biliary colic, one patient gallstone pancreatitis and 
one acute cholecystitis. One patient had a history of jaundice, and all four cases had elevated 
GGT above 40 mmol/l, three cases had ALP above 98 mmol/l. Post-operative, out of 23 cases, 
five cases had an ERCP, repeated ultrasound in three cases, persistence symptoms in four 
cases. 
  
Conclusions: GGT was the strongest predictor of choledocholithiasis. A normal GGT seems to 
be quite good at ruling out CBD stones. ALP was less accurate. Gallstone pancreatitis is not a 
good predictor, but it is importance to exclude choledocholithiasis before/during 










In the 30-year era of laparoscopic cholecystectomy, two questions have not clearly been 
answered in the intermediate-risk groups1,2 of choledocholithiasis. First, the most cost-
effectiveness modality to identify CBD stones, and secondly if  CBD stone found how to deal 
with it?3 
 
IOC is one modality for detecting CBD stones, but in published literature, there is little benefit 
in performing IOC routinely4. Selective IOC is the most common strategy, but no data support 
its benefit or which tests should be selected for which indication5,6. The indication for 
selective IOC would be abnormal liver enzymes and/or dilated biliary system on pre-operative 
ultrasound. Accordingly, the patients would be categorized as an intermediate-risk group for 
choledocholithiasis7. Cases with mild gallstone pancreatitis would also fall into this group. 
Jaundice patients would be in a high-risk group and thus justify pre-operative endoscopic 
retrograde cholangiopancreaticogram (ERCP), which reflect our current practice. 
 
There is still an ongoing debate if IOC is cost-effective and reliability either as a routine or 
selective modality8–11. In routine use, the systemic review of eight randomised trials showed 
no benefit in the prevention of a retained CBD stone4. IOC advantages are relatively low-cost 
and it does not require advanced laparoscopic skills, although you need the availability of 
mobile fluoroscopy. IOC has 59%-100% sensitivity and 93% -100% specificity to detect CBD 
stones12. The disadvantages of IOC are a longer operation time by 16 minutes, technical 
difficulty in acute inflammation and anatomical variation like a short cystic duct13. 
Furthermore, it could potentially lead to a CBD injury or false-positive results which can lead 
to unnecessary CBD explorations or invasive procedures (postoperative ERCP). Few studies 
are evaluating the sensitivity or specificity of pre-operative tests in detecting CBD stone 
among intermediate-risk groups2,5,14,15.  
 
The other unresolved issue is the treatment algorithm when detecting a filling defect on IOC. 
Options are performing an immediate operative CBD exploration, post-operative ERCP or 
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clinical observation and imaging follow up. Our current practice is to perform a post-operative 
ERCP. CBD exploration is reserved for failed endoscopic management.  
 
As clearly seen in the literature, there are no universal guidelines for the use of IOC7,16–18. 
There are two role-players in MRCP and endoscopic ultrasound for the pre-operative imaging 
of the bile duct, but in a limited resource environment, this cannot be accessed routinely. 
Also, an efficient, cost-effective approach that avoids unnecessary investigations and 
unnecessary risk for the patient. Our study would correlate if intermediate-risk groups 
warrant any further intervention of the CBD. 
  
Materials and methods 
A retrospective analysis of a prospectively maintained database for all patients who 
underwent a cholecystectomy with intraoperative cholangiogram at Groote Schuur Hospital 
in the Acute Care Surgery and Hepato-Pancreato-Biliary units between 1st of January 2015 
and 31st December 2016. Standard demographic variables including age and gender were 
documented as well as pre-operative symptoms, indications of cholecystectomy (biliary colic, 
gallstone pancreatitis, ascending cholangitis, and acute cholecystitis) were mentioned, 
preoperative LFTs (bilirubin, GGT, ALP, AST and ALT), IOC findings, post-operative abdomen 
ultrasound (dilated CBD), MRCP, ERCP, and persistence symptoms were detailed. The data 
was collected from patients' hospital files, operation notes, images on GSH pacs and blood 
results on NHLS online tool.  
  
Data was exported to Stata version 13.0 (Stata Corp., College Station, TX, USA) for analysis. 
For descriptive statistics, categorical values were summarised as frequencies and 
percentages. The chi-square test (or Fisher’s exact test) were used to compare categorical 
variables by the positivity of IOC. Continuous variables (all non-normally distributed per 
Shapiro-Wilk test) were summarised using medians with interquartile range. The Kruskal-
Wallis test was used to compare continuous variables by IOC positivity.  
 
The required data collection and analysis of this study was approved by the Faculty of Health 






During the two-year study period, a total of 237 laparoscopic cholecystectomies were 
performed. In this cohort, 23/237 (9.7%) patients fell into the intermediate-risk group 
requiring an IOC. 17/23 (73.4%) were female and the indications for the cholecystectomy 
were biliary colic (12/23; 52.2%), gallstone pancreatitis (8/23; 34.9%), acute cholecystitis 
presentation in two cases, and one case with ascending cholangitis. Twenty-one patients had 
elevated GGT more than 40 mmol/l, and seven patients had ALP less than 98 mmol/l, eight 
patients had an ALP more than 98 mmol/l and less than 200 mmol/l, eight patients had an 
ALP above 200 mmol/l, no patient had elevated serum bilirubin as this is considered a high-
risk group patient which would be managed by pre-operatively ERCP. The results are 
summarised in Table 3. 
  
In this study (4/23 or 17.4%) of the intermediate-risk group had choledocholithiasis. (figure 
15). The four cases who had positive findings on IOC: the median age was 44.5 years (36-58), 
one case was a male (25%), CBD diameter on ultrasound was between 6-7 mm (median 
6.5mm). The indications for cholecystectomy in this subgroup were two cases with biliary 
colic, one case of acute cholecystitis and one case of ascending cholangitis. One case had a 
history of jaundice. Pre-operative LFTs,  four cases had raised GGT more than 40 mmol/l, and 
one case had ALP less than 98 and 3 cases ALP was between 98 and 200 mmol/l. two cases 
had AST more than 35 and three cases had ALT more than 35 mmol/l. Summarised in Tables 
3-4. 
  
Postoperatively; four cases who had a positive IOC had a post-operative ERCP for stones 
extraction. No case had a CBD exploration, out of 23 cases three had a repeat ultrasound, no 




Figure 93 Case number 16 showed a filling defect in CBD (arrow). 
 
  















Demographic    
Age (years), median (IQR) 41.0 (31-55) 44.5 (36-58) 41 (29-59) 
Male Sex, n (%) 6 (26.1%) 1 (25.0%) 5 (33.3%) 
Ultrasound     
CBD size (mm), median (IQR) 6.0 (6-7) 6.5 (6-7) 6 (6-9) 
Indication for cholecystectomy    
Biliary colic 12 (57.2%) 2 (50.0%) 7 (44.7%) 
Gallstone pancreatitis, n (%) 8 (34.8%) 1 (25.0%) 6 (40.0%) 
Acute cholecystitis, n (%) 2 (8.7%) 1 (25.0%) 1 (6.7%) 
Ascending cholangitis, n (%) 1 (4.4%) 0 (0.0%) 1 (6.7%) 
History of Jaundiced, n (%) 8 (34.8%) 1 (25.0%) 5 (33.3%) 
Laboratory    
AST > 35, n (%) 8 (34.8%) 2 (50.0%) 4 (26.7%) 
ALT > 35, n (%) 11 (47.8%) 3 (75.0%) 9 (60.0%) 
GGT >40, n (%) 21 (91.3%) 4 (100.0%) 13 (86.7%) 
GGT, n (%)    
<40 2 (8.7%) 0 (0.0%) 2 (13.3%) 
40 to <150 8 (34.8%) 1 (25.0%) 5 (33.3%) 
150 to <400 8 (34.8%) 2 (50.0%) 4 (26.7%) 
>400 5 (21.8%) 1 (25.0%) 4 (26.7%) 
ALP >98, n (%) 16 (69.6%) 3 (75.0%) 9 (60.0%) 
ALP, n (%)    
<98 7 (30.4%) 1 (25.0%) 6 (40.0%) 
98 to <200 8 (34.8%) 3 (75.0%) 2 (13.3%) 
>200 8 (34.8%) 0 (0.0%) 7 (46.7%) 








Table 4: Correlates of a positive IOC  
Characteristic Crude OR (95%CI) 
Age (years) 1.02 (0.95-1.10) 
CBD size (mm)  0.72 (0.19-1.54) 
Male sex 0.68 (0.01-11.40) 
Biliary colic  1.14 (0.07-19.68) 
History of jaundice 0.68 (0.01-11.40) 
GGT>40 0.66 (0.05-inf) 
ALP>98 1.94 (0.12-122.22) 
ALT>35 1.14 (0.07-19.68) 
AST>35 2.59 (0.14-48.00) 














Table 5: Post-operative characteristics of the study participants 
Characteristic Summary 
Common bile duct exploration, n (%) 0 (0%) 
Post – ERCP, n (%) 4 (17.4%) 
Repeat ultrasonography, n (%) 3 (13.0%) 
New MRCP, n (%) 0 (0%) 
Repeat surgery, n (%) 0 (0%) 




This study aimed to identify the most predictive test for CBD stones pre-cholecystectomy, but 
another interested finding in this study was: 23 of 237 patients in the Groote Schuur practice 
fell into the intermediate group and four of these had proven choledocholithiasis. In the 
literature, the most commonly used are ultrasound, history of jaundice, biliary pancreatitis, 
CBD dilatation, and pre-operative LFT’s to estimate the risk of having CBD stones14,15. We 
found that the four cases who had positive IOC’s had elevated GGT of more than 40 mmol/l, 
which was not surprising as the 23 patients who were planned to have IOC, 21  had raised 
GGT levels. In our analysis, a raised ALP of more than 98 mmol/l was found in 75% which 
correlates with the literature of 79.5 %14. All our patient’s bilirubin was within the normal 
range or slightly raised. As seen in universal guidelines significantly increased bilirubin is 
considered to be in the high-risk group for which an ERCP is indicated pre-operatively. AST 
and ALT more than 35 mmol/l occurred in 50% and 75%, consequently within our study 
analysis, the sensitivity is 63% and 71.6%2. In this study, gallstone pancreatitis did not predict 
the presence of CBD stones, however, it is beneficial to exclude CBD stones by IOC or pre-
operatively MRCP, as it may lead to critical consequences7. 
 
There is very little data from Africa about IOC to compare with our clinical practice and 
outcomes. One study from Egypt19 which attempted to define the role of IOC in laparoscopic 
cholecystectomy showed pre-operative ALP elevated in 82% which is in keeping with our 
analysis of 75% above 98 mmol/l. However, the CBD was dilated in 48% wherein our series it 
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was 17% more than 8 mm. Interesting, all four cases who had a positive filling defect had a 
normal CBD diameter. As in the literature20,21, the CBD diameter on abdominal ultrasound has 
low sensitivity for prediction of CBD stones. They concluded that the value of IOC is high in 
comparison to the minimal complications. Moreover, it has higher diagnostic accuracy than 
MRCP; it saved another admission for the patient who underwent intra-operative evaluation 
19. There is no data from South Africa regarding IOC as it is not commonly used in South African 
institutions where they rely mainly on ERCP for managing CBD stones as a diagnostic and 
therapeutic procedure instead of IOC22. 
 
The retrospective nature is a serious limitation of this study. Also considering the shallow 
sample size (n=23), the study has low power to detect differences. However, it suggests where 
differences could be rather than affirmatively showing these differences. For example, it 
suggests those with positive IOC’s are more likely to be of higher age which is somehow 
significant. In the published guidelines the age above 55 years is categorised as a moderate 
predictor for choledocholithiasis, but one cannot be affirmative about this finding since the 
statistical power is low. 
 
One of the recommendations from this study is the need to conduct ongoing prospective 
research. Establishing a gallstone registry might even contribute to the standardisation of 
care. As we practice in limited-resource environments, institutions cannot routinely offer 
reliable, accurate tools for identification of choledocholithiasis such as MRCP, intra-operative 
U/S or even ERCP. Pre-operative predicted modules such as LFT and IOC selectively as 




A normal GGT has good negative predictive value. In a limited resources facility, IOC is cost-
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ALP Alkaline phosphatase 
ALT Alanine transaminase 
AST Aspartate transaminase 
CBD Common bile duct 
EEL Endoscopic electrohydraulic lithotripsy 
ELL Endoscopic laser lithotripsy 
EML Endoscopic mechanical lithotripsy 
EPBD Endoscopic papillary balloon dilatation 
ERCP Endoscopic retrograde cholangiopancreatogram 
EUS Endoscopic ultrasound 






IOC Intra-operative cholangiogram 
IOU Intra-operative ultrasound 
LFT 
mg 
Liver function test 
Milligram 
mm Millimetre 
mmol/l Millimole per litre  
MRCP Magnetic resonance cholangiopancreatogram 
SAGES Society of American Gastrointestinal and Endoscopic Surgeon 
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